RESUMEN
BACKGROUND: Micro- and macrovascular diseases are common in patients with type 2 diabetes mellitus (T2D) and may be partly caused by nocturnal hypoxemia. The study aimed to characterize the composition of nocturnal hypoxemic burden and to assess its association with micro- and macrovascular disease in patients with T2D. METHODS: This cross-sectional analysis includes overnight oximetry from 1247 patients with T2D enrolled in the DIACORE (DIAbetes COhoRtE) study. Night-time spent below a peripheral oxygen saturation of 90% (T90) as well as T90 associated with non-specific drifts in oxygen saturation (T90non - specific), T90 associated with acute oxygen desaturation (T90desaturation) and desaturation depths were assessed. Binary logistic regression analyses adjusted for known risk factors (age, sex, smoking status, waist-hip ratio, duration of T2D, HbA1c, pulse pressure, low-density lipoprotein, use of statins, and use of renin-angiotensin-aldosterone system inhibitors) were used to assess the associations of such parameters of hypoxemic burden with chronic kidney disease (CKD) as a manifestation of microvascular disease and a composite of cardiovascular diseases (CVD) reflecting macrovascular disease. RESULTS: Patients with long T90 were significantly more often affected by CKD and CVD than patients with a lower hypoxemic burden (CKD 38% vs. 28%, p < 0.001; CVD 30% vs. 21%, p < 0.001). Continuous T90desaturation and desaturation depth were associated with CKD (adjusted OR 1.01 per unit, 95% CI [1.00; 1.01], p = 0.008 and OR 1.30, 95% CI [1.06; 1.61], p = 0.013, respectively) independently of other known risk factors for CKD. For CVD there was a thresholdeffect, and only severly and very severly increased T90non-specific was associated with CVD ([Q3;Q4] versus [Q1;Q2], adjusted OR 1.51, 95% CI [1.12; 2.05], p = 0.008) independently of other known risk factors for CVD. CONCLUSION: While hypoxemic burden due to oxygen desaturations and the magnitude of desaturation depth were significantly associated with CKD, only severe hypoxemic burden due to non-specific drifts was associated with CVD. Specific types of hypoxemic burden may be related to micro- and macrovascular disease.
Asunto(s)
Diabetes Mellitus Tipo 2 , Hipoxia , Humanos , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/complicaciones , Masculino , Femenino , Persona de Mediana Edad , Estudios Transversales , Anciano , Hipoxia/diagnóstico , Hipoxia/sangre , Hipoxia/epidemiología , Hipoxia/fisiopatología , Factores de Riesgo , Oximetría , Ritmo Circadiano , Saturación de Oxígeno , Angiopatías Diabéticas/diagnóstico , Angiopatías Diabéticas/epidemiología , Angiopatías Diabéticas/fisiopatología , Angiopatías Diabéticas/sangre , Factores de Tiempo , Insuficiencia Renal Crónica/diagnóstico , Insuficiencia Renal Crónica/epidemiología , Insuficiencia Renal Crónica/fisiopatología , Insuficiencia Renal Crónica/sangreRESUMEN
Rapid eye movement sleep is associated with distinct changes in various biomedical signals that can be easily captured during sleep, lending themselves to automated sleep staging using machine learning systems. Here, we provide a perspective on the critical characteristics of biomedical signals associated with rapid eye movement sleep and how they can be exploited for automated sleep assessment. We summarise key historical developments in automated sleep staging systems, having now achieved classification accuracy on par with human expert scorers and their role in the clinical setting. We also discuss rapid eye movement sleep assessment with consumer sleep trackers and its potential for unprecedented sleep assessment on a global scale. We conclude by providing a future outlook of computerised rapid eye movement sleep assessment and the role AI systems may play.
RESUMEN
BACKGROUND: Pregnancy complications related to hypertension can affect both mother and newborn. Pulse wave attenuation (PWA) captured through fingertip photoplethysmography (PPG) provide valuable insights into maternal acute hemodynamic and autonomic vascular function. Here, we quantify the nocturnal dynamics of PWA during early pregnancy and assess their association with the development of gestational hypertension, preeclampsia and gestational diabetes. METHODS: PWA dynamics were assessed on overnight polysomnography-derived PPG signals from a cohort of 2714 pregnant women (mean age: 26.8â±â5.5âyears) enrolled in the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b). We determined the average duration (PWA duration ) and depth (PWA depth ) of PWA events in all women. RESULTS: Odds ratio (OR) analysis-adjusted common confounders indicates that an average PWA duration greater than 8.74âs was associated with the increased risk of gestational hypertension [ORâ=â1.75 (1.27-2.39), P â<â0.001]. Similarly, average PWA depth greater than 1.19 was associated with an increased risk of preeclampsia [ORâ=â1.53 (1.01-2.33), P â=â0.045] and gestational diabetes [ORâ=â1.66 (1.01-2.73), P â=â0.044]. CONCLUSION: PWA attenuation dynamics during early pregnancy predict the risk of developing gestational hypertension and diabetes condition for women in their later trimesters. Potentially obtainable from smart wearable consumer devices, PWA analysis offers a low-cost, accessible and scalable marker that can enhance the management of pregnancy-induced cardiometabolic issues.
Asunto(s)
Diabetes Gestacional , Hipertensión Inducida en el Embarazo , Preeclampsia , Humanos , Embarazo , Femenino , Diabetes Gestacional/fisiopatología , Diabetes Gestacional/diagnóstico , Adulto , Preeclampsia/fisiopatología , Preeclampsia/diagnóstico , Hipertensión Inducida en el Embarazo/fisiopatología , Hipertensión Inducida en el Embarazo/diagnóstico , Dedos/irrigación sanguínea , Adulto Joven , Pletismografía , Análisis de la Onda del Pulso , FotopletismografíaRESUMEN
This study explores the efficacy of our novel and personalized brain-computer interface (BCI) therapy, in enhancing hand movement recovery among stroke survivors. Stroke often results in impaired motor function, posing significant challenges in daily activities and leading to considerable societal and economic burdens. Traditional physical and occupational therapies have shown limitations in facilitating satisfactory recovery for many patients. In response, our study investigates the potential of motor imagery-based BCIs (MI-BCIs) as an alternative intervention. In this study, MI-BCIs translate imagined hand movements into actions using a combination of scalp-recorded electrical brain activity and signal processing algorithms. Our prior research on MI-BCIs, which emphasizes the benefits of proprioceptive feedback over traditional visual feedback and the importance of customizing the delay between brain activation and passive hand movement, led to the development of RehabSwift therapy. In this study, we recruited 12 chronic-stage stroke survivors to assess the effectiveness of our solution. The primary outcome measure was the Fugl-Meyer upper extremity (FMA-UE) assessment, complemented by secondary measures including the action research arm test, reaction time, unilateral neglect, spasticity, grip and pinch strength, goal attainment scale, and FMA-UE sensation. Our findings indicate a remarkable improvement in hand movement and a clinically significant reduction in poststroke arm and hand impairment following 18 sessions of neurofeedback training. The effects persisted for at least 4 weeks posttreatment. These results underscore the potential of MI-BCIs, particularly our solution, as a prospective tool in stroke rehabilitation, offering a personalized and adaptable approach to neurofeedback training.
RESUMEN
BACKGROUND: Bursting non-sustained cardiac arrhythmia events, are a common observation during sleep. OBJECTIVES: We hypothesized nocturnal arrhythmia episode durations could follow a power-law, whose exponent could predict long-term clinical outcomes. METHODS: We defined 'nocturnal arrhythmia avalanche' (NAA) as any instance of a drop in electrocardiogram (ECG) template-matched R-R intervals ≥30% of R-R baseline, followed by a return to 90% of the baseline. We studied NAA in ECG recordings obtained from the Sleep Heart Health Study (SHHS), the Osteoporotic Fractures in Men Study (MrOS) Sleep and Multi-Ethnic Study of Atherosclerosis (MESA) studies. The association of the nocturnal arrhythmia durations with a power-law distribution was evaluated, and the association of derived power-law exponents (α) with major adverse cardiovascular events and mortality assessed with multivariable Cox regression. RESULTS: n=9176 participants were studied. NAA episodes distribution was with a consistent power-law versus comparator distributions in all datasets studied (Positive log likelihood ratio of power-law vs. exponential in MESA: 83%; SHHS: 69%; MrOS: 81%; power-law vs. log-normal in MESA: 95%; SHHS: 35% and MrOS: 64%). The NAA power law exponent (α) showed a significant association of with adverse CV outcomes (Association with CV mortality: SHHS (HR = 1.39[1.07-1.79], p=0.012); MrOS (HR = 1.42[1.02-1.94], p=0.039; Association with CV events: MESA (HR = 3.46[1.46-8.21], p=0.005)) in multivariable Cox regression, after adjusting for conventional CV risk factors and nocturnal ectopic rate. CONCLUSION: The NAA power-law exponent is a reproducible, predictive marker for incident cardiovascular events and mortality.